Insider Shareholders with Direct Ownership of Genprex, Inc. (GNPX)
This section provides a comprehensive overview of the insiders with direct ownership of Genprex, Inc. (GNPX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Genprex, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Catherine M Vaczy
EVP GC Chief Strategy Officer |
265,000 | 0 | 265,000 $219,950 | 2 |
Apr 21, 2023
Added 7.02%
|
|
Hermant Kumar
Chief Mfgr & Tech Officer |
200,000 | 0 | 200,000 $166,000 | 1 |
Feb 18, 2023
Added 50.0%
|
|
Ryan M. Confer
President, CEO and CFO |
391,348 | 1,126 | 39,138 $32,484 | 4 |
Dec 05, 2024
Added 42.88%
|
|
John Rodney Varner
Chairman, President and CEO |
625,000 | 2,642 | 26,352 $21,872 | 2 |
Feb 18, 2024
Reduced 9.11%
|
|
Mark Stanley Berger
Chief Medical Officer |
263,250 | 1,319 | 23,056 $19,136 | 3 |
Dec 05, 2024
Added 44.18%
|
|
Brent M Longnecker
Director |
143,545 | 0 | 8,220 $6,822 | 3 |
Dec 05, 2024
Added 36.62%
|
|
William R Wilson Jr.
Director |
128,545 | 0 | 7,845 $6,511 | 2 |
Dec 05, 2024
Added 37.71%
|
|
Toscano Jose Antonio Moreno
Director |
128,545 | 0 | 7,845 $6,511 | 2 |
Dec 05, 2024
Added 37.71%
|